The FDA clearance comes just three months after the company received EU MDR Class IIb certification for its configurable disease management platform.
Huma receives 510(k) Class II clearance for its disease-agnostic platform

The FDA clearance comes just three months after the company received EU MDR Class IIb certification for its configurable disease management platform.